These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


285 related items for PubMed ID: 16966107

  • 1. Trichloroethylene cancer epidemiology: a consideration of select issues.
    Scott CS, Chiu WA.
    Environ Health Perspect; 2006 Sep; 114(9):1471-8. PubMed ID: 16966107
    [Abstract] [Full Text] [Related]

  • 2. Key issues in the modes of action and effects of trichloroethylene metabolites for liver and kidney tumorigenesis.
    Caldwell JC, Keshava N.
    Environ Health Perspect; 2006 Sep; 114(9):1457-63. PubMed ID: 16966105
    [Abstract] [Full Text] [Related]

  • 3. Key issues in the role of peroxisome proliferator-activated receptor agonism and cell signaling in trichloroethylene toxicity.
    Keshava N, Caldwell JC.
    Environ Health Perspect; 2006 Sep; 114(9):1464-70. PubMed ID: 16966106
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. TCE, designated a known carcinogen, now the focus of ongoing research.
    McNeil C.
    J Natl Cancer Inst; 2013 Oct 16; 105(20):1518-9. PubMed ID: 24082065
    [No Abstract] [Full Text] [Related]

  • 9. Issues in the pharmacokinetics of trichloroethylene and its metabolites.
    Chiu WA, Okino MS, Lipscomb JC, Evans MV.
    Environ Health Perspect; 2006 Sep 16; 114(9):1450-6. PubMed ID: 16966104
    [Abstract] [Full Text] [Related]

  • 10. Trichloroethylene: Mechanistic, epidemiologic and other supporting evidence of carcinogenic hazard.
    Rusyn I, Chiu WA, Lash LH, Kromhout H, Hansen J, Guyton KZ.
    Pharmacol Ther; 2014 Jan 16; 141(1):55-68. PubMed ID: 23973663
    [Abstract] [Full Text] [Related]

  • 11. Trichloroethylene cancer risk: simplified calculation of PBPK-based MCLs for cytotoxic end points.
    Bogen KT, Gold LS.
    Regul Toxicol Pharmacol; 1997 Feb 16; 25(1):26-42. PubMed ID: 9056499
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Human health effects of trichloroethylene: key findings and scientific issues.
    Chiu WA, Jinot J, Scott CS, Makris SL, Cooper GS, Dzubow RC, Bale AS, Evans MV, Guyton KZ, Keshava N, Lipscomb JC, Barone S, Fox JF, Gwinn MR, Schaum J, Caldwell JC.
    Environ Health Perspect; 2013 Mar 16; 121(3):303-11. PubMed ID: 23249866
    [Abstract] [Full Text] [Related]

  • 16. Trichloroethylene risk assessment: a review and commentary.
    Jollow DJ, Bruckner JV, McMillan DC, Fisher JW, Hoel DG, Mohr LC.
    Crit Rev Toxicol; 2009 Mar 16; 39(9):782-97. PubMed ID: 19852561
    [Abstract] [Full Text] [Related]

  • 17. The perils and promise of modern risk assessment: the example of trichloroethylene.
    Kester JE, Clewell HJ.
    Clin Occup Environ Med; 2004 Aug 16; 4(3):497-512, vi-vii. PubMed ID: 15325318
    [Abstract] [Full Text] [Related]

  • 18. Mutagenicity of trichloroethylene and its metabolites: implications for the risk assessment of trichloroethylene.
    Moore MM, Harrington-Brock K.
    Environ Health Perspect; 2000 May 16; 108 Suppl 2(Suppl 2):215-23. PubMed ID: 10807553
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.